Navigation Links
Cadient Interactive's Will Reese to Discuss Strategies for Engaging Physicians Online at Eighth Annual ePharma Summit
Date:2/4/2009

WEST CONSHOHOCKEN, Pa., Feb. 4 /PRNewswire/ -- Will Reese, Chief Innovation Officer of Cadient Interactive, will join a panel of pharmaceutical marketing executives to discuss best practices for effectively reaching physicians online, as part of the 2009 IIRUSA ePharma Summit at the Hyatt Regency Philadelphia at Penn's Landing.

On Tuesday, February 10, 2009 at 3:45 p.m., Reese will participate in a panel discussion exploring "How Can Pharma Companies More Effectively Reach MDs Online?" The session will provide an update on physician portals, social networks, relationship marketing (eCRM), and sales/marketing integration of online physician activities.

Reese will offer a practical perspective on how best to leverage the Web to engage physicians, as well as best practices for ensuring your messages resonate. Additionally, Reese and the panelists will address what types of content physicians look for online; CRM MD programs; the effectiveness of emerging technologies in the sales process; and how to effectively measure physician-targeted initiatives.

"It's my hope that this discussion will be viewed as the 'practical panel' - a back-to-basics look at how to effectively engage physicians with the right content at the right time via the right medium," said Will Reese, Chief Innovation Officer, Cadient Interactive. "Simplicity and clarity are critical to building effective relationships with physicians both on and offline. The fundamentals of physician-based marketing remain intact and highly relevant; it's the vehicles used to accomplish these efforts that are changing. Today's pharmaceutical marketers need to carefully and thoughtfully integrate these new tools to effectively engage physicians."

Reese leads Cadient Interactive's innovation team to identify strategic opportunities within the healthcare space to drive deeper relationships with professionals, consumers, and payers. He carries more
'/>"/>

SOURCE Cadient Interactive
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cadient Group Expands Award-Winning Capabilities with Key New Hires
2. Cadient Group Ranked 34th in Deloittes Fast 50 Program for Greater Philadelphia
3. Cadient Group Named to the Philadelphia 100(R) as One of the Regions Fastest-Growing Privately-Held Companies
4. Cadient Group Appoints Andrew le Blanc as Creative Director
5. Cadient Groups GEL Interactive Technologies Celebrates Major Milestones for Immerse Exhibit Platform: 500th Exhibit Implementation and 250,000th Healthcare Professional Registered with Immerse Exhibit Platform
6. Cadient Group President and CEO, Stephen Wray, Named 2008 Ernst & Young Entrepreneur Of The Year(R) in Greater Philadelphia Region
7. 2008 IN-AWE Awards Recognize Cadient Groups Innovative Use of Digital Media
8. Cadient Group Continues Winning Streak; Receives Multiple Honors at 2008 Pharmaceutical Advertising and Marketing Excellence Awards
9. Cadient Group Appoints Barbara Dowling to Senior Vice President Customer Engagements
10. Cadient Group Receives Multiple Awards at 2008 DTC National Advertising Awards
11. Cadient Group Receives Multiple Nominations for 2008 DTC National Advertising Awards

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009).../ -- Physicians at Beth Israel Deaconess Medical C...y demonstrating the potential for automated analys...OR Analyzer System® to assist in rapidly ruli...ncy department (ED ) patients with chest pain. The...e of cCTA has potential to significantly reduce un...
(Date:11/30/2009)... response to a "cocaine-cues" video, active cocain...ity in brain regions linked to drug craving, accor...gy,s Brookhaven National Laboratory. The results, ...e , suggest that clinical interventions designed t... cocaine abusers stop using drugs and avoid relaps...
(Date:11/30/2009)...ore often than younger people, study finds, , ... people who are problem drinkers consume more alco...finds, possibly because they need more alcohol to ...y released this month, people dependent on alcohol... a week, on average. By contrast, younger alcoholi...
(Date:11/30/2009)...30 Baxa Corporation is sponsoring ...re of safety" means in today,s pharmacy environmen...a Culture of Safety in Pharmacy ," features a pane...experiences with culture of safety, what it takes ...ole of technology in enabling or inhibiting safe p...
(Date:11/30/2009)...swire/ -- A new study has found that 27% of Medica...ustomers have a current intention to shop for and ...re is up from 20% in 2008. Over the past four yea...eading indicator of actual switching patterns. W...tually will leave their current insurer for anothe...
Breaking Medicine News(10 mins):Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3Health News:Brain scan study shows cocaine abusers can control cravings 2Health News:Brain scan study shows cocaine abusers can control cravings 3Health News:Binge Drinking Not Just a Rite of the Young 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:More Seniors Considering Health Insurance Switch 2
...RNewswire-FirstCall/ - IMRIS Inc. (TSX: IM) ("IMRI...iversity Huashan Hospital in Shanghai, China has s... department. Huashan Hospital will be the first in...dure without moving the patient. The project inclu...
...THAT ASTHMA PATIENTS WHO STOP USING ASTHMA CONTROL... , WASHINGTON , April 15 A new nationwide tel...ost asthma patients know the risks of "uncontrolle...s are not present. Data from The Asthma G.A.P. ...
...andards for First National Measures of Hospital Ef...art Angioplasty, and Pneumonia , , Detailed Hospi...group.org/cp , , WASHINGTON, April 15 Though it...ospitals still have failed to implement standards ...
... 15 Baptist Memorial Health Care Corp. em... phase of the "Our House is Your House" capital ca...emmons Wilson Family Center for Good Grief as they...g out to their colleagues to make donations. , , ...
...d NEW YORK, April 15 HLTH Corporation (Nasdaq: ... WebMD Health Corp. (Nasdaq: WBMD ), today annou...cial results for the three months ended March 31, ...ults. , , Investors can access the call via web...
...f endoscopic ultrasound (EUS) examination is its l... lesion. The differential diagnosis between benign...sses based on the EUS appearance is difficult and ...chnique that can be applied during ultrasound (US)...
Other Medicine News:Health News:National Survey Reveals Gap in 'Uncontrolled Asthma' Knowledge - Putting Asthma Patients at Risk for Serious Health Consequences 2Health News:National Survey Reveals Gap in 'Uncontrolled Asthma' Knowledge - Putting Asthma Patients at Risk for Serious Health Consequences 3Health News:National Survey Reveals Gap in 'Uncontrolled Asthma' Knowledge - Putting Asthma Patients at Risk for Serious Health Consequences 4Health News:Leapfrog Group Hospital Survey Finds Majority of Hospitals Fail to Meet Important Quality Standards 2Health News:Leapfrog Group Hospital Survey Finds Majority of Hospitals Fail to Meet Important Quality Standards 3Health News:Leapfrog Group Hospital Survey Finds Majority of Hospitals Fail to Meet Important Quality Standards 4Health News:Baptist Colleagues Raise $1 Million for Baptist Trinity Hospice House and Kemmons Wilson Family Center for Good Grief 2Health News:HLTH and WebMD Announce First Quarter Earnings Release Date and Conference Call 2Health News:Can EUS elastography help distinguish benign from malignant tissue? 2
(Date:11/30/2009)... Va., Nov. 30 Intelliject, Inc. to...ntis U.S. for a novel epinephrine auto-injector, i..., sanofi-aventis U.S. shall be responsible for man... be responsible for the on-going development and f...ined certain co-promotion rights in the territory....
(Date:11/30/2009)... OAKS, Calif., Nov. 30 A... will present updated long-term safety and efficac...onic immune (idiopathic) thrombocytopenic purpura ...Nplate study in a pediatric setting as well as in ...he 2009 American Society of Hematology (ASH) Annua...
(Date:11/30/2009)... November 30 , ... the European Union in,the Last 10 Years , ...announced today that the,European Commission has g...edarone - 400mg Tablets) in all 27 European member...sion positive opinion issued on September 25, 2009...
Breaking Medicine Technology:Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 3Amgen Highlights Data to be Presented at ASH 2Amgen Highlights Data to be Presented at ASH 3Amgen Highlights Data to be Presented at ASH 4Amgen Highlights Data to be Presented at ASH 5Amgen Highlights Data to be Presented at ASH 6Amgen Highlights Data to be Presented at ASH 7Amgen Highlights Data to be Presented at ASH 8Amgen Highlights Data to be Presented at ASH 9Amgen Highlights Data to be Presented at ASH 10Amgen Highlights Data to be Presented at ASH 11Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation 2Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation 3Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation 4Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation 5Insmed Announces Addition to the Russell 3000 28R 29 Index 12842 1Insmed Announces Addition to the Russell 3000 28R 29 Index 12842 2Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic CXA 101 in Patients with Complicated Urinary Tract Infections 4668 1Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic CXA 101 in Patients with Complicated Urinary Tract Infections 4668 2Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market 50365 1Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market 50365 2Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market 50365 3
Hunkeler IOL Manipulator
Guimaraes ICL Manipulator
Lester IOL Manipulator
...scopes are individually adjusted for perfect focus...s, along with Keeler's wide angle light beam and i... pupil size, you will see the clearest and largest...longer life battery and fast charge capability. Wi...
Medicine Products: